Analysis of 30 patients with persistent or recurrent squamous cell carcinoma of the cervix within one year after concurrent chemoradiotherapy

about

Analysis of 30 patients with persistent or recurrent squamous cell carcinoma of the cervix within one year after concurrent chemoradiotherapy

Item

http://www.wikidata.org/entity/Q41785844

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Analysis of 30 patients with p ...... r concurrent chemoradiotherapy

@en

type

Item

label

Analysis of 30 patients with p ...... r concurrent chemoradiotherapy

@en

prefLabel

Analysis of 30 patients with p ...... r concurrent chemoradiotherapy

@en

P1476

Analysis of 30 patients with p ...... r concurrent chemoradiotherapy

@en

P2093

Dong-Yan Cao

http://www.w3.org/2001/XMLSchema#string

Jia-Xin Yang

http://www.w3.org/2001/XMLSchema#string

Keng Shen

http://www.w3.org/2001/XMLSchema#string

Shi-Ping Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group Study

Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix.

Adjuvant chemotherapy following concurrent chemoradiotherapy for uterine cervical cancer with lymphadenopathy.

Chemotherapy for recurrent cervical cancer.

The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy.

Chemotherapy for advanced and recurrent cervical carcinoma: results from cooperative group trials.

Time course and outcome of central recurrence after radiation therapy for carcinoma of the cervix.

Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.

Risk assessment tool for distant recurrence after platinum-based concurrent chemoradiation in patients with locally advanced cervical cancer: a Korean gynecologic oncology group study.

Neoadjuvant chemotherapy with weekly paclitaxel and carboplatin followed by chemoradiation in locally advanced cervical carcinoma: a pilot study.

P304

227-231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7497/J.ISSN.2095-3941.2013.04.007

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259355507

http://www.w3.org/2001/XMLSchema#string

P698

24349833

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

3860346

http://www.w3.org/2001/XMLSchema#string